Status:
UNKNOWN
Behavior of the Iliofemoral Segment
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Artery Stenosis
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Peripheral artery diseases (PAD) are associated with an overall increased risk of mortality and morbidity, as a consequence of fatal or non-fatal vascular events, mainly due to the total or partial oc...
Eligibility Criteria
Inclusion
- Patient's age \> 65 years old
- Patient with Glomerular filtration rate \> 60ml/mn
- Patient affiliated to the French Health insurance system
- Patient with a preoperative duplex scan of the lower limbs
- Patient with an indication of CT scan with either diagnostic or preoperative purposes
- Patient referred for endovascular procedure (aortic or peripheral), with an indication of CTA comprising the CFA region, without significant lesions of the external iliac and common femoral arteries (control group) or patients referred for endovascular stenting of the common femoral artery (stent group)
Exclusion
- Patient with significant below the knee arterial lesions according the duplex scan analysis
- Hip arthroplasty.
- Hip pain and stiffness caused by hip arthritis.
- Patient under guardianship
- Patient deprived of liberty
- Patient under court protection
- Patient objecting to the use of his/her data for this research
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06113172
Start Date
November 15 2023
End Date
December 15 2024
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014